Skip to main content
Home
language-selector-globe Slovenia | en
Choose Location
language-selector-globe Slovenia |
EnglishSlovenian
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Latin America | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Israel | he
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Slovenia | sl
Slovenia | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Novartis | en
Sandoz | en
Egypt | en
South Africa | en
Turkey | tr
language-selector-globe si
Choose Location
language-selector-globeSlovenia
EnglishSlovenian
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latin America | es
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
Slovenia | sl
Slovenia | en
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in Slovenia 
      • Country Leadership Team 
      • Strategy 
      • Diversity, Equity and Inclusion 
      • People and culture 
      • Products 
      • Contacts 
      Novartis in Slovenia. Scientist in laboratory About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Products 
      Older patient and younger caregiver Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Products 
      • Pipeline 
      • Adverse Event Reporting 
      • Clinical studies 
      Elderly gentleman at a doctor's appointment Healthcare Professionals
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
      • Reporting 
      Two people holding hands ESG
    • Media 
      • News Archive 
      • Media Contact 
      Man reading newspaper Media
    • Careers 
      • Careers at Novartis in Slovenia 
      • How We Work 
      • Wellbeing 
      • Diversity, Equity and Inclusion 
      • BioCamp 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • Awards and Recognition 
      Man and woman behind computer Careers
    • Development and production of innovative medicines 
    • BioCamp 2024 
    Scientist, Novartis in Slovenia Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort ascending
Job Title Site Location Division Business Functional Area Date Posted Sort ascending
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales 05 June 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales 05 June 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales 05 June 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales 05 June 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales 05 June 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales 05 June 2024
District Manager Changsha (Hunan Province) China International Innovative Medicines Sales 05 June 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales 05 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Sourcing Manager R&D, Drug Development Hyderabad (Office) India Operations CTS Procurement 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
QC Analyst IV - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality 04 June 2024
Enterprise Architecture and Integration Director for Commercial Areas INSURGENTES Mexico Operations CTS Technology Transformation 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales 04 June 2024
县域主任/县域主管 Luoyang (Henan Province) China International Innovative Medicines Sales 04 June 2024
Change Control Coordinator Hyderabad (Office) India Operations Innovative Medicines Technical Operations 03 June 2024
Analyst Hyderabad (Office) India Operations CTS Marketing 02 June 2024
Medical Head Radioligand Therapy Rueil-Malmaison France International Innovative Medicines Research & Development 02 June 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance 31 May 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others 31 May 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development 30 May 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development 30 May 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) India Operations CTS Technology Transformation 29 May 2024
(高级)医药代表 /(资深)产品专员 Guangzhou (Guangdong Province) China International Innovative Medicines Sales 29 May 2024
Equipment Operator Stein Aargau Switzerland Operations Innovative Medicines Technical Operations 28 May 2024
Senior Specialist, Master Batch Record (MBR) Design Indianapolis USA Operations CTS Technology Transformation 28 May 2024
Therapeutic Area Biomarker Lead Cambridge (USA) USA Biomedical Research Pharma Research Research & Development 28 May 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others 28 May 2024
SMR Fuzhou (Fujian Province) China International Innovative Medicines Sales 28 May 2024
Senior Molecular Imaging Expert (Senior Principal Scientist) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development 27 May 2024
Senior Lead, TA Medical(General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development 27 May 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others 23 May 2024
Senior Analyst - Data & Products Hyderabad (Office) India Operations CTS Marketing 22 May 2024
HSE Facilities Maintenances Specialist Cambridge (USA) USA Operations CTS Facilities & Administration 22 May 2024
(高级)地区经理 Guiyang (Guizhou Province) China International Innovative Medicines Sales 22 May 2024
Sr. Spec. DDIT ISC IES Hyderabad (Office) India Operations CTS Technology Transformation 21 May 2024
Maintenance Technician (Mechatronics) Schaftenau Austria Operations Innovative Medicines Technical Operations 21 May 2024
Document Quality Manager Hyderabad (Office) India Biomedical Research Pharma Research Research & Development 21 May 2024
ALTERNANT Expert en développement des compétences Paris Headquarter (Novartis Pharma S.A.S.) France Innovative Medicines Others 21 May 2024
Equipment Engineer Changping County (Beijing) China Operations Innovative Medicines Technical Operations 21 May 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing 20 May 2024
Analyst – Patient Oriented Programs Hyderabad (Office) India Operations CTS Marketing 20 May 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Slovenia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Media
  • Career
Media
  • News Archive
Our Portfolio
  • Novartis Products
  • Novartis Pipeline
Other Novartis websites
  • Global site
Footer Bottom
© 2024 Novartis d.o.o.
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience